Skip to content
CancerIndex

Publication

Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis.

Zhifang Zhang, Annie Yang, Anthony K Park, Shyambabu Chaurasiya, Sang-In Kim, Jianming Lu, Isabel Monroy, Hannah Valencia, Courtney Chen, Supriya Deshpande, Yuman Fong, Yanghee Woo

Molecular therapy. OncologySep 17, 2026PMID 42440454doi:10.1016/j.omton.2026.201266 PMC13333358Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 19, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260919-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Peritoneal metastasis (PM) is the leading cause of treatment failure and death from gastric cancer (GC). We evaluated the antitumor and immunogenic effects of CF17, an oncolytic chimeric orthopoxvirus, in a novel syngeneic mouse model of GCPM. CF17 was tested in mouse GC cell lines (ACKPY3944 and…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.